Johnson & Johnson Press Releases

Get JNJ Alerts
*Delayed - data as of Sep. 22, 2014  -  Find a broker to begin trading JNJ now
Exchange: NYSE
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Filtered By
Ordered By

Pioneering Gene Editing Research Celebrated This Week During 2014 Dr. Paul Janssen Award for Biomedical Research Events
9/9/2014 10:20:00 AM - PR Newswire

Jury Decides for Wexler Wallace LLP Client Against J&J Subsidiary: $3.27 Million
9/5/2014 5:25:00 PM - PR Newswire

Johnson & Johnson Responds to Ebola Crisis With Commitment to Accelerate Vaccine Program in Collaboration With the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid
9/4/2014 12:01:00 AM - PR Newswire

Johnson & Johnson to Participate in 2014 Morgan Stanley Health Care Conference
9/3/2014 7:45:00 AM - PR Newswire

Janssen Affiliate Cilag GmbH International Acquires Covagen AG
8/25/2014 8:25:00 AM - PR Newswire

Nodality, Inc. Expands Intellectual Property Estate, Announces U.S. Patent for Broadly Enabling Single Cell Network Profiling (SCNP) Technology Platform
8/14/2014 8:00:00 AM - Business Wire

U.S. FDA Approves INVOKAMET™ (canagliflozin/metformin HCl) for the Treatment of Adults with Type 2 Diabetes
8/8/2014 7:15:00 PM - PR Newswire

Nodality Expands Senior Leadership Team, Appoints Kathleen LaPorte as Chief Business Officer
8/6/2014 8:00:00 AM - Business Wire

Janssen Launches Online Healthy Minds Video Series
8/5/2014 9:00:00 AM - PR Newswire

IBM Elects Two New Members to Its Board of Directors
7/29/2014 4:34:00 PM - Business Wire

Johnson & Johnson Announces $5 Billion Share Repurchase Program
7/21/2014 5:00:00 PM - PR Newswire

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2014
7/21/2014 11:10:00 AM - PR Newswire

Johnson & Johnson Reports 2014 Second-Quarter Results:
7/15/2014 7:45:00 AM - PR Newswire

Cordis Corporation Launches SABER™ PTA Dilatation Catheter to Complement Portfolio of Peripheral Arterial Disease Treatments
7/1/2014 9:00:00 AM - Business Wire

Johnson & Johnson Completes Divestiture Of Ortho-Clinical Diagnostics To The Carlyle Group
6/30/2014 4:30:00 PM - PR Newswire